Testing effectiveness (Phase 2)Study completedNCT05630872
What this trial is testing
Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis
Who this might be right for
HIV-associated Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 30